The burgeoning popularity of semaglutide , initially for diabetes , is creating significant attention within the British Isles, prompting a notable shift in medication trends. Access these treatments remains a complex challenge , with National Health Service provision currently limited and private clinics offering treatment at a higher cost . Quest